483 Leading Pharma Jan 2012

483 Leading Pharma Jan 2012

Michael Klapal FDA$119.00 - Available Now

FDA investigators audited the Leading Pharma - Fairfield, NJ, United States facility and issued inspectional observations (via FDA 483) on 23 Jan 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Jan 2012
  • Location: Fairfield, United States
  • FEI: 3001611969
Add To Cart